Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations
Remimazolam is an ultra‐short acting benzodiazepine under development for procedural sedation and general anesthesia. Population pharmacokinetic analysis (PopPK) was conducted for remimazolam with arterial and venous samples previously, but results were limited by arterial‐venous concentration diffe...
Main Authors: | Jie Zhou, Laura Curd, Lauren L. Lohmer, Joachim Ossig, Frank Schippers, Thomas Stoehr, Virginia Schmith |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12875 |
Similar Items
-
A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation
by: Jie Zhou, et al.
Published: (2021-07-01) -
Remimazolam: The future of its sedative potential
by: Basavana Gouda Goudra, et al.
Published: (2014-01-01) -
Remimazolam (CNS 7056): an Emerging Sedative and General Anaesthetic
by: Sumit Bansal, et al.
Published: (2018-03-01) -
Efficacy and Safety of Remimazolam for Procedural Sedation: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis
by: Bo-Jyun Jhuang, et al.
Published: (2021-07-01) -
Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent
by: Gavin J. Kilpatrick
Published: (2021-07-01)